These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32301968)

  • 1. Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.
    Murray E; Tomaszewski M; Guzik TJ
    Cardiovasc Res; 2020 Jun; 116(7):e87-e89. PubMed ID: 32301968
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19.
    Steardo L; Steardo L; Zorec R; Verkhratsky A
    Acta Physiol (Oxf); 2020 Jul; 229(3):e13473. PubMed ID: 32223077
    [No Abstract]   [Full Text] [Related]  

  • 3. [ACE2 and coronavirus - a question of balance and dynamics?].
    Lundström A; Sandén P
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.
    Tan CS; Yeoh SF; Long CM
    Ann Acad Med Singap; 2020 Jun; 49(6):398-400. PubMed ID: 32712639
    [No Abstract]   [Full Text] [Related]  

  • 5. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.
    Tsioufis C; Dimitriadis K; Tousoulis D
    Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334
    [No Abstract]   [Full Text] [Related]  

  • 6. Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association?
    Giollo A; Cioffi G; Rossini M; Viapiana O; De Simone G
    Eur J Intern Med; 2020 Oct; 80():106-107. PubMed ID: 32553588
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 challenging cell biology.
    Bullerdiek J
    Protoplasma; 2020 May; 257(3):619-620. PubMed ID: 32333127
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Parkinsonism: Is There Evidence for Concern?
    Monje MHG; Martínez-Fernández R
    Mov Disord; 2020 Oct; 35(10):1725. PubMed ID: 33068472
    [No Abstract]   [Full Text] [Related]  

  • 9. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.
    Ferrandi PJ; Alway SE; Mohamed JS
    J Appl Physiol (1985); 2020 Oct; 129(4):864-867. PubMed ID: 32673162
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2.
    Qiu Y; Zhao YB; Wang Q; Li JY; Zhou ZJ; Liao CH; Ge XY
    Microbes Infect; 2020; 22(4-5):221-225. PubMed ID: 32199943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
    Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
    Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
    Brojakowska A; Narula J; Shimony R; Bander J
    J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
    Turgeon RD; Zieroth S; Bewick D; Chow CM; Clarke B; Cowan S; Fordyce CB; Fournier A; Gin K; Gupta A; Hardiman S; Jackson S; Lau B; Leong-Poi H; Mansour S; Marelli A; Quraishi AR; Roifman I; Ruel M; Sapp J; Singh G; Small G; Virani S; Wood DA; Krahn A
    Can J Cardiol; 2020 Aug; 36(8):1180-1182. PubMed ID: 32502522
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential infectious risk from the pets carrying SARS-CoV-2.
    Wang H; Wang F; Wang H; Zhao Q
    Travel Med Infect Dis; 2020; 35():101737. PubMed ID: 32380152
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
    Delpino MV; Quarleri J
    Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
    Siniorakis E; Arvanitakis S; Nikolopoulos I; Elkouris M
    mBio; 2020 May; 11(3):. PubMed ID: 32444383
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral submucous fibrosis and COVID-19: Perspective on comorbidity.
    Sarode SC; Sarode GS; Gondivkar S; Gadbail A; Gopalakrishnan D; Patil S
    Oral Oncol; 2020 Aug; 107():104811. PubMed ID: 32505551
    [No Abstract]   [Full Text] [Related]  

  • 18. Could angiotensin-converting enzyme 1
    Dević Pavlić S; Nadalin S; Starčević Čizmarević N; Buretić-Tomljanović A; Radojčić Badovinac A; Ristić S
    J Renin Angiotensin Aldosterone Syst; 2020; 21(3):1470320320957157. PubMed ID: 32928023
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs.
    Ciulla MM
    Hypertens Res; 2020 Sep; 43(9):985-986. PubMed ID: 32523133
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.
    Wu C; Ye D; Mullick AE; Li Z; Danser AHJ; Daugherty A; Lu HS
    Hypertension; 2020 Oct; 76(4):e29-e30. PubMed ID: 32673509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.